Delivery Order SPE2DE24D0021-SPE2D625F1REN
- Not listed
- Fisher Scientific Company L.L.C., a major supplier of laboratory and medical equipment to federal agencies, received a $2,140.14 fixed-price delivery order from the Defense Department's Medical Supply Chain division on June 18, 2025. The contract covers procurement of a kit for real-time polymerase chain reaction (PCR) DNA polymerase, single-step substrate, and related 3-plate configuration materials. Performance will take place in Pittsburgh, Pennsylvania, with an ultimate completion date of...
- Fisher Scientific Company L.L.C. has been awarded a fixed-price delivery order valued at $6,420.42 for one kit of real-time polymerase chain reaction (PCR) DNA primer with single-step substrate and caption plates, to be delivered to Pittsburgh, Pennsylvania. The contract was awarded on August 28, 2025, with an ultimate completion date of September 17, 2025. This delivery order represents a child contract with no set-aside designation, awarded through open competition to support the Medical...
- Fisher Scientific Company L.L.C. was awarded a $3,956.00 delivery order contract on June 18, 2025, for kit real-time polymerase chain reaction (RT PCR) RNA with 1 step builtin hot start gel. This fixed-price contract with economic price adjustment has an ultimate completion date of July 1, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Medical Supply Chain, a defense-focused federal agency, with no set-aside designation applied. As a child contract...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $10,700.70 on June 6, 2025, for the supply of PCR DNA polymerase kit components with single-step substrate script 3 plating capabilities. The contract, which extends through June 30, 2025, supports the Defense Medical Supply Chain and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger procurement vehicle and was awarded through open competition with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 7, 2025, valued at $4,929.58 for the procurement of a real-time PCR (polymerase chain reaction) 1ml DNA multiplex master mix kit. This fixed-price delivery order with economic price adjustment terms is set to be completed by August 14, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Medical Supply Chain division of the Department of Defense through open competition with no set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,911.80 on September 3, 2025, for the supply of a kit for reverse transcription polymerase chain reaction (RT PCR) 96-well plate region of interest testing. The contract is a fixed price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 15, 2025. The award was made without a set-aside designation through open competition, and performance will take place in...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $17,174.10 on August 7, 2025, for the procurement of PCR (polymerase chain reaction) system reagents—specifically SYS PCR IV 1st Strain Superscript 50 reaction kits. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 18, 2025, and will be performed at Fisher Scientific's location in Pittsburgh, PA. The contract was awarded without a set-aside designation, reflecting open...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,782.05 for FG TaqMan Fast Universal PCR supplies on July 29, 2025, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment was awarded without a set-aside designation by the Medical Supply Chain division of the Defense Department. The work will be performed in Pittsburgh, Pennsylvania. As a child contract under a larger vehicle, this delivery order represents a discrete...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $8,325.00 on August 22, 2025, for the procurement of PCR (polymerase chain reaction) IV 1st strand superscript reagents in 50 reaction quantities. This fixed-price contract with economic price adjustment provisions will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 5, 2025. The contract was awarded without set-aside designation through open competition to the Defense or Civilian...
- Fisher Scientific Company L.L.C. received a delivery order contract award from the Medical Supply Chain, a defense-focused federal agency, on August 6, 2025, for the procurement of FG TaqMan Fast PCR UMM reagent in 50-milliliter quantities. The contract is valued at $6,089.00 under a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of August 18, 2025. The award utilized open competition with no set-aside designation, and the place of...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F1RENDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,230.00 on August 22, 2025, for the procurement of a kit containing real-time polymerase chain reaction (PCR) DNA primer with a single-step protocol and probe for detection purposes. The contract, which is fixed price with economic price adjustment pricing, is classified as a child contract and was issued without a set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 8, 2025. The contracting agency is the Medical Supply Chain, a defense-focused organization supporting federal supply requirements. Fisher Scientific, a major supplier of scientific products and laboratory supplies to federal agencies since its SAM.gov registration in 2001, regularly competes for and wins federal procurement opportunities across multiple scientific domains. The company's extensive portfolio includes advanced laboratory equipment and specialized testing solutions supporting research and healthcare initiatives. This delivery order represents a routine procurement of diagnostic testing components, consistent with the broader market for molecular biology reagents and supplies utilized by federal defense and medical agencies for laboratory and testing operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/22/25 |